Home » Topics » BioWorld Science

BioWorld Science
RSS

SpectrumX reports in vitro neutralizing efficacy of SPC-069 against SARS-CoV-2 variants

Sep. 20, 2021

Kissei Pharmaceutical discovers EGLN1 inhibitors

Sep. 20, 2021

Researchers report improved DHODH inhibitors, anti-coronavirus activity

Sep. 20, 2021

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Sep. 20, 2021

Rasarfin, a dual Ras and ARF6 inhibitor with promising antitumor activity

Sep. 20, 2021

MEGs and MBK-2 clusters regulate P granule dynamics and coarsening

Sep. 20, 2021

TSHA-104 AAV9 gene-replacement therapy for Leigh syndrome shows promising results

Sep. 20, 2021

Discovery of novel compounds with potent activity against resistant bacteria

Sep. 20, 2021

Single-cell transcriptome of human melanocytes during development, aging and malignancy

Sep. 20, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...